You are here
BIOPROTECTION SYSTEMS CORP.
UEI: M1KKDAY5YUU9
# of Employees: 60
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of a safe and efficacious vaccine for Rift Valley fever virus
Amount: $100,000.00This application addresses the USDA NIFA "Global Food Security and Hunger" primary societal challenge area by developing a countermeasure against a potential agricultural disease threat - Rift Valley ...
SBIRPhase I2011Department of Agriculture -
Development of Multivalent Vaccines Against Yellow Fever and Arena Viruses
Amount: $599,895.00DESCRIPTION (provided by applicant): Indigenous population, travelers and troops present in Africa and South America are clearly at risk of exposure to several arenaviruses. Several human pathogenic a ...
SBIRPhase I2010Department of Health and Human Services National Institutes of Health -
Improved Venezuelan equine encephalitis virus vaccines
Amount: $749,999.00We hypothesize that the application of the broad-spectrum immune-stimulatory and -modulatory HyperAcute alphaGal Adjuvant Technology will enhance the potency and effectiveness of VEEV vaccine candidat ...
SBIRPhase II2009Department of Defense Office for Chemical and Biological Defense -
Multiple Indication Adjuvants
Amount: $99,985.00The objective of this study is to demonstrate the efficacy and broad applicability of the human immune-modulating alphaGal Adjuvant Technology for antiviral vaccine development. We will use viral vacc ...
SBIRPhase I2008Department of Defense Office for Chemical and Biological Defense